Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 99.2114.8319.94309.00-25.23

What is the latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS is 99.21 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202599.21
Mar202414.83
Mar202319.94
Mar2022309.00
Mar2021-25.23

How is Core EBITDA Growth of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 99.21
568.98
Mar2024 14.83
-25.63
Mar2023 19.94
-93.55
Mar2022 309
Positive
Mar2021 -25.23 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹112.1 Cr -9% -1% 1.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-9%

-1%

1.8%

SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses